Evaluation of community pharmacist ability to ensure the safe use of oral anticancer agents: A nationwide survey in Japan

Shinya Suzuki, Rick Abbott, Hiroomi Sakurai, Kenji Kawasumi, Philip E. Johnson, Makoto Tahara, Masakazu Yamaguchi, Shinichiro Saito, Gary C Yee, Kazushi Endo

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Objectives: A recent study of community pharmacists in Canada reported that they required additional education. We conducted a survey of community pharmacists to evaluate the adequacy of education and training in oral anticancer agents in Japan.Methods: Between May and June 2014, community pharmacists were asked to complete a questionnaire by using two different survey strategies, one online and one via postal mail.Results: Three hundred community pharmacists responded to an online survey and 283 community pharmacists responded to a mailed survey. Only 6-10% of respondents felt that they had received adequate education in oncology or oral chemotherapy. Although 81% of Japanese pharmacists had attended at least one continuing education event related to oncology in the past 2 years, only 54% felt comfortable dispensing oral anticancer agents and only 40% felt comfortable educating patients about oral chemotherapy. In a multivariate analysis, confidence in educating patients about oral chemotherapy was associated with an understanding of chemotherapy cycles and doses (odds ratio = 4.89, 95% confidence interval [2.53-9.45]) and the number of continuing education events they had attended (odds ratio = 1.67, 95% confidence interval [1.35-2.08]).Conclusions: This is the first report to evaluate whether community pharmacists are equipped to ensure the safe use of oral anticancer agents in Japan. The results are similar to those previously reported for Canadian pharmacists, namely a low rate of positive responses for education in oncology and oral chemotherapy, demonstrating a similar need for additional education and training in oral chemotherapy.

Original languageEnglish (US)
Article numberhyx015
Pages (from-to)413-421
Number of pages9
JournalJapanese Journal of Clinical Oncology
Volume47
Issue number5
DOIs
StatePublished - May 1 2017

Fingerprint

Pharmacists
Antineoplastic Agents
Japan
Drug Therapy
Education
Continuing Education
Odds Ratio
Confidence Intervals
Surveys and Questionnaires
Postal Service
Canada
Multivariate Analysis

Keywords

  • Community pharmacy
  • Japanese pharmacy
  • Oral anticancer agents
  • Oral chemotherapy
  • Questionnaire

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Cite this

Suzuki, S., Abbott, R., Sakurai, H., Kawasumi, K., Johnson, P. E., Tahara, M., ... Endo, K. (2017). Evaluation of community pharmacist ability to ensure the safe use of oral anticancer agents: A nationwide survey in Japan. Japanese Journal of Clinical Oncology, 47(5), 413-421. [hyx015]. https://doi.org/10.1093/jjco/hyx015

Evaluation of community pharmacist ability to ensure the safe use of oral anticancer agents : A nationwide survey in Japan. / Suzuki, Shinya; Abbott, Rick; Sakurai, Hiroomi; Kawasumi, Kenji; Johnson, Philip E.; Tahara, Makoto; Yamaguchi, Masakazu; Saito, Shinichiro; Yee, Gary C; Endo, Kazushi.

In: Japanese Journal of Clinical Oncology, Vol. 47, No. 5, hyx015, 01.05.2017, p. 413-421.

Research output: Contribution to journalArticle

Suzuki, S, Abbott, R, Sakurai, H, Kawasumi, K, Johnson, PE, Tahara, M, Yamaguchi, M, Saito, S, Yee, GC & Endo, K 2017, 'Evaluation of community pharmacist ability to ensure the safe use of oral anticancer agents: A nationwide survey in Japan', Japanese Journal of Clinical Oncology, vol. 47, no. 5, hyx015, pp. 413-421. https://doi.org/10.1093/jjco/hyx015
Suzuki, Shinya ; Abbott, Rick ; Sakurai, Hiroomi ; Kawasumi, Kenji ; Johnson, Philip E. ; Tahara, Makoto ; Yamaguchi, Masakazu ; Saito, Shinichiro ; Yee, Gary C ; Endo, Kazushi. / Evaluation of community pharmacist ability to ensure the safe use of oral anticancer agents : A nationwide survey in Japan. In: Japanese Journal of Clinical Oncology. 2017 ; Vol. 47, No. 5. pp. 413-421.
@article{05d4785624e04bf4be30596ede613e09,
title = "Evaluation of community pharmacist ability to ensure the safe use of oral anticancer agents: A nationwide survey in Japan",
abstract = "Objectives: A recent study of community pharmacists in Canada reported that they required additional education. We conducted a survey of community pharmacists to evaluate the adequacy of education and training in oral anticancer agents in Japan.Methods: Between May and June 2014, community pharmacists were asked to complete a questionnaire by using two different survey strategies, one online and one via postal mail.Results: Three hundred community pharmacists responded to an online survey and 283 community pharmacists responded to a mailed survey. Only 6-10{\%} of respondents felt that they had received adequate education in oncology or oral chemotherapy. Although 81{\%} of Japanese pharmacists had attended at least one continuing education event related to oncology in the past 2 years, only 54{\%} felt comfortable dispensing oral anticancer agents and only 40{\%} felt comfortable educating patients about oral chemotherapy. In a multivariate analysis, confidence in educating patients about oral chemotherapy was associated with an understanding of chemotherapy cycles and doses (odds ratio = 4.89, 95{\%} confidence interval [2.53-9.45]) and the number of continuing education events they had attended (odds ratio = 1.67, 95{\%} confidence interval [1.35-2.08]).Conclusions: This is the first report to evaluate whether community pharmacists are equipped to ensure the safe use of oral anticancer agents in Japan. The results are similar to those previously reported for Canadian pharmacists, namely a low rate of positive responses for education in oncology and oral chemotherapy, demonstrating a similar need for additional education and training in oral chemotherapy.",
keywords = "Community pharmacy, Japanese pharmacy, Oral anticancer agents, Oral chemotherapy, Questionnaire",
author = "Shinya Suzuki and Rick Abbott and Hiroomi Sakurai and Kenji Kawasumi and Johnson, {Philip E.} and Makoto Tahara and Masakazu Yamaguchi and Shinichiro Saito and Yee, {Gary C} and Kazushi Endo",
year = "2017",
month = "5",
day = "1",
doi = "10.1093/jjco/hyx015",
language = "English (US)",
volume = "47",
pages = "413--421",
journal = "Japanese Journal of Clinical Oncology",
issn = "0368-2811",
publisher = "Oxford University Press",
number = "5",

}

TY - JOUR

T1 - Evaluation of community pharmacist ability to ensure the safe use of oral anticancer agents

T2 - A nationwide survey in Japan

AU - Suzuki, Shinya

AU - Abbott, Rick

AU - Sakurai, Hiroomi

AU - Kawasumi, Kenji

AU - Johnson, Philip E.

AU - Tahara, Makoto

AU - Yamaguchi, Masakazu

AU - Saito, Shinichiro

AU - Yee, Gary C

AU - Endo, Kazushi

PY - 2017/5/1

Y1 - 2017/5/1

N2 - Objectives: A recent study of community pharmacists in Canada reported that they required additional education. We conducted a survey of community pharmacists to evaluate the adequacy of education and training in oral anticancer agents in Japan.Methods: Between May and June 2014, community pharmacists were asked to complete a questionnaire by using two different survey strategies, one online and one via postal mail.Results: Three hundred community pharmacists responded to an online survey and 283 community pharmacists responded to a mailed survey. Only 6-10% of respondents felt that they had received adequate education in oncology or oral chemotherapy. Although 81% of Japanese pharmacists had attended at least one continuing education event related to oncology in the past 2 years, only 54% felt comfortable dispensing oral anticancer agents and only 40% felt comfortable educating patients about oral chemotherapy. In a multivariate analysis, confidence in educating patients about oral chemotherapy was associated with an understanding of chemotherapy cycles and doses (odds ratio = 4.89, 95% confidence interval [2.53-9.45]) and the number of continuing education events they had attended (odds ratio = 1.67, 95% confidence interval [1.35-2.08]).Conclusions: This is the first report to evaluate whether community pharmacists are equipped to ensure the safe use of oral anticancer agents in Japan. The results are similar to those previously reported for Canadian pharmacists, namely a low rate of positive responses for education in oncology and oral chemotherapy, demonstrating a similar need for additional education and training in oral chemotherapy.

AB - Objectives: A recent study of community pharmacists in Canada reported that they required additional education. We conducted a survey of community pharmacists to evaluate the adequacy of education and training in oral anticancer agents in Japan.Methods: Between May and June 2014, community pharmacists were asked to complete a questionnaire by using two different survey strategies, one online and one via postal mail.Results: Three hundred community pharmacists responded to an online survey and 283 community pharmacists responded to a mailed survey. Only 6-10% of respondents felt that they had received adequate education in oncology or oral chemotherapy. Although 81% of Japanese pharmacists had attended at least one continuing education event related to oncology in the past 2 years, only 54% felt comfortable dispensing oral anticancer agents and only 40% felt comfortable educating patients about oral chemotherapy. In a multivariate analysis, confidence in educating patients about oral chemotherapy was associated with an understanding of chemotherapy cycles and doses (odds ratio = 4.89, 95% confidence interval [2.53-9.45]) and the number of continuing education events they had attended (odds ratio = 1.67, 95% confidence interval [1.35-2.08]).Conclusions: This is the first report to evaluate whether community pharmacists are equipped to ensure the safe use of oral anticancer agents in Japan. The results are similar to those previously reported for Canadian pharmacists, namely a low rate of positive responses for education in oncology and oral chemotherapy, demonstrating a similar need for additional education and training in oral chemotherapy.

KW - Community pharmacy

KW - Japanese pharmacy

KW - Oral anticancer agents

KW - Oral chemotherapy

KW - Questionnaire

UR - http://www.scopus.com/inward/record.url?scp=85027117465&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85027117465&partnerID=8YFLogxK

U2 - 10.1093/jjco/hyx015

DO - 10.1093/jjco/hyx015

M3 - Article

C2 - 28184436

AN - SCOPUS:85027117465

VL - 47

SP - 413

EP - 421

JO - Japanese Journal of Clinical Oncology

JF - Japanese Journal of Clinical Oncology

SN - 0368-2811

IS - 5

M1 - hyx015

ER -